New Nordic Healthbrands AB (OSTO:NNH) ROCE %: -5.73% (As of Mar. 2026)

What is New Nordic Healthbrands AB ROCE %?

New Nordic Healthbrands AB OSTO:NNH +2.50% 64 ROCE % is -5.73% as of Mar. 2026. GuruFocus rates OSTO:NNH with a GF Score™ of 64/100 and a GF Value™ of kr19.91 (Significantly Undervalued). The stock has 4 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. New Nordic Healthbrands AB's annualized ROCE % for the quarter that ended in Mar. 2026 was -5.73%.

New Nordic Healthbrands AB (OSTO:NNH) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

New Nordic Healthbrands AB ROCE % Related Terms

New Nordic Healthbrands AB ROCE % Historical Data

* Premium members only.

The historical data trend for New Nordic Healthbrands AB's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

New Nordic Healthbrands AB ROCE % Chart

New Nordic Healthbrands AB Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

ROCE %

Get a 7-Day Free Trial

24.45

-3.06

-3.28

-3.82

14.02

New Nordic Healthbrands AB Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
ROCE %	Get a 7-Day Free Trial															19.15	14.61	10.44	14.25	-5.73

64GF Score

New Nordic Healthbrands AB OSTO:NNH

ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

New Nordic Healthbrands AB ROCE % Calculation

New Nordic Healthbrands AB's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2025 )		(A: Dec. 2024 )		(A: Dec. 2025 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2025 )		(A: Dec. 2024 )		(A: Dec. 2025 )
	=	14.644	/	( ( (249.104 - 146.027)	+	(246.15 - 140.29) )	/ 2 )
	=	14.644	/	( (103.077	+	105.86)	/ 2 )
	=	14.644	/	104.4685
	=	14.02 %

New Nordic Healthbrands AB's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	-6.024	/	( ( (246.15 - 140.29)	+	(264.32 - 159.922) )	/ 2 )
	=	-6.024	/	( ( 105.86	+	104.398 )	/ 2 )
	=	-6.024	/	105.129
	=	-5.73 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

Frequently Asked Questions Learn more about ROCE % →

What does a ROCE % of -5.73% mean?

New Nordic Healthbrands AB (OSTO:NNH) has a ROCE % of -5.73% as of Mar. 2026.

Is New Nordic Healthbrands AB's ROCE % too high?

New Nordic Healthbrands AB's current ROCE % is -5.73%. Overall, New Nordic Healthbrands AB has a GF Score™ of 64/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.

How does New Nordic Healthbrands AB's ROCE % compare to KHC and GIS?

New Nordic Healthbrands AB's ROCE % of -5.73% can be compared against companies in the Consumer Packaged Goods industry. The industry median ROCE % is 8.74. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROCE % for a Consumer Packaged Goods company?

The median ROCE % among Consumer Packaged Goods companies is 8.74, based on 1,936 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROCE % mean?

A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Consumer Packaged Goods industry, the median ROCE % is 8.74 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. New Nordic Healthbrands AB's current ROCE % is -5.73%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is New Nordic Healthbrands AB stock overvalued right now?

Based on GuruFocus' analysis, New Nordic Healthbrands AB (OSTO:NNH) is currently considered Significantly Undervalued. The stock's GF Value™ is kr19.91, compared to a current price of kr12.30 — trading 38.2% below its estimated fair value. The current ROCE % is -5.73%. New Nordic Healthbrands AB's overall GF Score™ is 64/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROCE % calculated?

ROCE % is calculated from a company's financial statements. For New Nordic Healthbrands AB (OSTO:NNH), the current ROCE % is -5.73% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is New Nordic Healthbrands AB (OSTO:NNH) Overvalued in 2026?

Based on GuruFocus' analysis, New Nordic Healthbrands AB stock appears to be undervalued. The current stock price of kr12.30 is trading 38.2% below its estimated GF Value™ of kr19.91. GuruFocus considers New Nordic Healthbrands AB to be Significantly Undervalued.

Key valuation signals for OSTO:NNH:

ROCE %: -5.73%
GF Value™: kr19.91 vs. price of kr12.30 (38.2% below fair value)
GF Score™: 64/100 with 4 warning signs

No single metric tells the full story. See the OSTO:NNH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

New Nordic Healthbrands AB Business Description

Industry Consumer Defensive Consumer Packaged Goods

Comparable Companies NGM:LOHILO NGM:HMPLY NGM:WONDR XSWX:NESN XPAR:BN BOG:NUTRESA TSE:2802 NSE:NESTLEIND SHSE:603288 KHC SHSE:600887 GIS SZSE:300999 LSE:ABF SGX:F34 DUB:KRZ HRL MEX:BIMBOA HKSE:00288 MKC

Address Sodra Forstadsgatan 3, Malmo, SWE, 211 43

Website http://www.newnordic.com

New Nordic Healthbrands AB develops herbal supplements, herbal remedies, and personal care products to satisfy specific health and beauty needs. The products are sold in North America, Europe, and Asia. Some products sold are Active legs, Active Liver, Apple Cider, Chili Burn, Clear brain, Ear tone, Equazen, Frutin gastro gel, Hair Gro, Hair Volume, Kilo trim, and Melissa Dream. Maximum revenue is generated from the Nordic region.

64GF Score

Get the complete analysis for OSTO:NNH

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr12.30

Price

kr19.91

GF Value

View OSTO:NNH Analysis

See ROCE % data for all stocks →